These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 24109538)

  • 1. Choroidal metastasis of non-small cell lung cancer that responded to gefitinib.
    Shimomura I; Tada Y; Miura G; Suzuki T; Matsumura T; Tsushima K; Terada J; Kurimoto R; Sakaida E; Sekine I; Takiguchi Y; Yamamoto S; Tatsumi K
    Case Rep Ophthalmol Med; 2013; 2013():213124. PubMed ID: 24109538
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Choroidal metastasis with adenocarcinoma of the lung treated with gefitinib.
    Inoue M; Watanabe Y; Yamane S; Kobayashi S; Arakawa A; Tsukahara T; Kaneko T; Kadonosono K
    Eur J Ophthalmol; 2010; 20(5):963-5. PubMed ID: 20383850
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Orbital metastasis secondary to pulmonary adenocarcinoma treated with gefitinib: a case report.
    Koma Y; Goto K; Yoshida C; Kimura K; Matsumoto Y; Koyama M; Nakashima N; Masuya D; Matsuoka H; Yoshimatsu H; Azumi A; Suzuki Y
    J Med Case Rep; 2012 Oct; 6():353. PubMed ID: 23079208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Total regression of brain metastases in non-small cell lung cancer patients harboring EGFR mutations treated with gefitinib without radiotherapy: two case reports.
    Chonan M; Narita N; Tominaga T
    BMC Res Notes; 2016 Jan; 9():2. PubMed ID: 26724810
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Therapeutic Changes in Bilateral Choroidal Metastasis from Non-Small Cell Lung Cancer with Response to Afatinib: A Case Report.
    Zhou HP; Tanaka R; Tsuji H
    Ocul Immunol Inflamm; 2020 Aug; 28(6):860-863. PubMed ID: 31013174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of clinical outcomes following gefitinib and erlotinib treatment in non-small-cell lung cancer patients harboring an epidermal growth factor receptor mutation in either exon 19 or 21.
    Lim SH; Lee JY; Sun JM; Ahn JS; Park K; Ahn MJ
    J Thorac Oncol; 2014 Apr; 9(4):506-11. PubMed ID: 24736073
    [TBL] [Abstract][Full Text] [Related]  

  • 7. EGFR-mutated lung adenocarcinoma with choroidal oligometastasis during treatment with gefitinib: a case report.
    Hashimoto T; Osoegawa A; Abe M; Oki R; Karashima T; Takumi Y; Kamada K; Miyawaki M; Sugio K
    Int Cancer Conf J; 2024 Jul; 13(3):204-208. PubMed ID: 38962043
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment of choroid metastasis from lung adenocarcinoma with bevacizumab-containing chemotherapy: A case report.
    Makabe K; Kurishima K; Shiozawa T; Miyazaki K; Ohara G; Kagohashi K; Satoh H; Hizawa N
    Exp Ther Med; 2016 Jan; 11(1):239-242. PubMed ID: 26889247
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Unrelenting Ocular Pain as a Masquerading Symptom of Occult Choroidal Metastasis.
    Deaner JD; Pointdujour-Lim R; Say EA; Shields CL
    Ocul Oncol Pathol; 2017 Jan; 3(1):56-59. PubMed ID: 28275605
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Liver metastasis predicts poorer prognosis in stage IV lung adenocarcinoma patients receiving first-line gefitinib.
    Wu KL; Tsai MJ; Yang CJ; Chang WA; Hung JY; Yen CJ; Shen CH; Kuo TY; Lee JY; Chou SH; Liu TC; Chong IW; Huang MS
    Lung Cancer; 2015 May; 88(2):187-94. PubMed ID: 25747806
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A multicenter phase II study to evaluate the efficacy and safety of gefitinib as first-line treatment for Korean patients with advanced pulmonary adenocarcinoma harboring EGFR mutations.
    Kim DW; Lee SH; Lee JS; Lee MA; Kang JH; Kim SY; Shin SW; Kim HK; Heo DS
    Lung Cancer; 2011 Jan; 71(1):65-9. PubMed ID: 20430469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A phase II trial of gefitinib monotherapy in pretreated patients with advanced non-small cell lung cancer not harboring activating EGFR mutations: implications of sensitive EGFR mutation test.
    Choi MK; Hong JY; Chang WJ; Kim MJ; Kim SM; Jung HA; Do IG; Choi YL; Sun JM; Ahn JS; Park K; Ahn MJ
    Cancer Chemother Pharmacol; 2015 Jun; 75(6):1229-36. PubMed ID: 25903122
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Erlotinib response of EGFR-mutant gefitinib-resistant non-small-cell lung cancer.
    Chang JW; Chou CL; Huang SF; Wang HM; Hsieh JJ; Hsu T; Cheung YC
    Lung Cancer; 2007 Dec; 58(3):414-7. PubMed ID: 17618013
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gefitinib treatment in patients with postoperative recurrent non-small-cell lung cancer harboring epidermal growth factor receptor gene mutations.
    Yokoyama Y; Sonobe M; Yamada T; Sato M; Menju T; Aoyama A; Sato T; Chen F; Omasa M; Date H
    Int J Clin Oncol; 2015 Dec; 20(6):1122-9. PubMed ID: 25953679
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tyrosine Kinase Inhibitors in the Treatment of Choroidal Metastases from Non-Small-Cell Lung Cancer: A Case Report and Review of Literature.
    Nair AG; Asnani HT; Mehta VC; Mehta SV; Pathak RS; Palkar AH; Gopinathan I
    Ocul Oncol Pathol; 2017 Jan; 3(1):28-33. PubMed ID: 28275600
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diffuse micronodular pulmonary metastasis of lung adenocarcinoma predicts gefitinib response in association with epidermal growth factor receptor mutations.
    Kobayashi M; Takeuchi T; Bandobashi K; Uemura Y; Ogawa Y; Ohtsuki Y; Taguchi H
    Anticancer Res; 2006; 26(2B):1621-6. PubMed ID: 16619582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Photodynamic Therapy for Choroidal Metastasis Tumor Control and Visual Outcomes in 58 Cases: The 2019 Burnier International Ocular Pathology Society Lecture.
    Shields CL; Khoo CTL; Mazloumi M; Mashayekhi A; Shields JA
    Ophthalmol Retina; 2020 Mar; 4(3):310-319. PubMed ID: 31953111
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Blurred vision due to choroidal metastasis as the first manifestation of lung cancer: a case report.
    Asteriou C; Konstantinou D; Kleontas A; Paliouras D; Samanidis G; Papadopoulou F; Barbetakis N
    World J Surg Oncol; 2010 Jan; 8():2. PubMed ID: 20064203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A case of choroidal metastasis of lung cancer successfully treated with erlotinib.
    Fujiu K; Kobayashi N; Miyamoto H; Suzuki H
    Gan To Kagaku Ryoho; 2012 Feb; 39(2):269-71. PubMed ID: 22333641
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor burden is predictive of survival in patients with non-small-cell lung cancer and with activating epidermal growth factor receptor mutations who receive gefitinib.
    Park JH; Kim TM; Keam B; Jeon YK; Lee SH; Kim DW; Chung DH; Kim YT; Kim YW; Heo DS
    Clin Lung Cancer; 2013 Jul; 14(4):383-9. PubMed ID: 23313171
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.